PCV39 - ASSESSMENT OF THE BUDGET IMPACT OF INTRAVENOUS FERRIC CARBOXYMALTOSE (FCM) FOR TREATING IRON DEFICIENCY ANEMIA IN CONGESTIVE HEART FAILURE PATIENTS IN GREECE
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.586
https://www.valueinhealthjournal.com/article/S1098-3015(18)33886-5/fulltext
Title :
PCV39 - ASSESSMENT OF THE BUDGET IMPACT OF INTRAVENOUS FERRIC CARBOXYMALTOSE (FCM) FOR TREATING IRON DEFICIENCY ANEMIA IN CONGESTIVE HEART FAILURE PATIENTS IN GREECE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33886-5&doi=10.1016/j.jval.2018.09.586
First page :
Section Title :
Open access? :
No
Section Order :
2478